Skip to main content
Premium Trial:

Request an Annual Quote

Prolexys to Make Proteomic Map of TB as Part of Imperial College Consortium

NEW YORK, July 28 (GenomeWeb News) - As part of a collaborative research project led by  ImperialCollege, London, Prolexys Pharmaceuticals will create a comprehensive protein-protein interaction map of Mycobacterium tuberculosis, the bacterium that causes tuberculosis, using its HyNet and HySpec platforms, the company said today in a statement.

 

Prolexys did not disclose detailed financial terms of the deal.

 

"The detailed protein interaction map will shed a light on potential mechanisms of TB latency and therefore facilitate the discovery of drugs that eliminate the latent infection," Gary Schoolnik, a consortium member and a professor of medicine at StanfordUniversity, said in the statement.

 

About 2 billion people worldwide carry latent TB, according to the statement.

 

The consortium is supported by a $20 million grant toImperialCollegefrom the Grand Challenges in Global Health initiative, which is itself supported by the Bill & Melinda Gates Foundation, the Wellcome Trust, and the Canadian Institutes of Health Research, Prolexys said.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.